We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$317M
AUM Growth
+$79.3M
Cap. Flow
+$66.9M
Cap. Flow %
21.11%
Top 10 Hldgs %
43.22%
Holding
98
New
36
Increased
16
Reduced
11
Closed
29

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$9.61M
2
BHC icon
Bausch Health
BHC
+$7.76M
3
MDT icon
Medtronic
MDT
+$7.64M
4
BIIB icon
Biogen
BIIB
+$6.02M
5
VTRS icon
Viatris
VTRS
+$5.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$13.7M
2
AGN
Allergan plc
AGN
+$7.44M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$6.22M
4
PBYI icon
Puma Biotechnology
PBYI
+$5.9M
5
ZBH icon
Zimmer Biomet
ZBH
+$5.88M

Sector Composition

Rank Sector Weight
1 Healthcare 67.88%
2 Technology 0.31%
3 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAE icon
76
Haemonetics
HAE
$3.97B
– –
-25,000
Closed -$1.12M
HUM icon
77
Humana
HUM
$44.8B
– –
-30,000
Closed -$5.34M
IWM icon
78
iShares Russell 2000 ETF
IWM
$81.8B
– –
-50,000
Closed -$6.22M
LGND icon
79
Ligand Pharmaceuticals
LGND
$5.76B
– –
-56,105
Closed -$2.7M
MRK icon
80
Merck
MRK
$322B
– –
-52,400
Closed -$2.87M
NBIX icon
81
Neurocrine Biosciences
NBIX
$16.5B
– –
-50,000
Closed -$1.99M
NKTR icon
82
Nektar Therapeutics
NKTR
$2.55B
– –
-6,667
Closed -$1.1M
OSUR icon
83
OraSure Technologies
OSUR
$268M
– –
-105,000
Closed -$687K
PBYI icon
84
Puma Biotechnology
PBYI
$453M
– –
-25,000
Closed -$5.9M
PTCT icon
85
PTC Therapeutics
PTCT
$6.15B
– –
-25,000
Closed -$1.52M
TXMD icon
86
TherapeuticsMD
TXMD
$24M
– –
-4,000
Closed -$1.21M
ZBH icon
87
Zimmer Biomet
ZBH
$18.5B
– –
-51,500
Closed -$5.88M
AERI
88
DELISTED
Aerie Pharmaceuticals
AERI
– –
-120,000
Closed -$3.76M
FLXN
89
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-50,000
Closed -$1.13M
IMMU
90
DELISTED
Immunomedics Inc
IMMU
– –
-50,000
Closed -$204K
AGN
91
DELISTED
Allergan plc
AGN
– –
-25,000
Closed -$7.44M
WCG
92
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-45,000
Closed -$4.12M
TSRO
93
DELISTED
TESARO, Inc.
TSRO
– –
-10,000
Closed -$574K
KND
94
DELISTED
Kindred Healthcare
KND
– –
-50,000
Closed -$1.19M
SPNC
95
DELISTED
Spectranetics Corp
SPNC
– –
-50,000
Closed -$1.74M
TLOG
96
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
– –
-100,000
Closed -$438K
DYAX
97
DELISTED
DYAX CORPORATION
DYAX
– –
-150,000
Closed -$2.51M
MDVN
98
DELISTED
MEDIVATION, INC.
MDVN
– –
-50,000
Closed -$3.23M
1 2 3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2015 Portfolio in Review

As of Q2 2015, Iguana Healthcare Management held 98 positions worth $317M, up 33% from $238M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management deployed $66.9M of net new capital in Q2 2015, opening 36 new positions and adding to 16 existing holdings. Its largest new stake was Amgen: 60,000 shares worth $9.21M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 82% a quarter earlier, followed by Technology and Real Estate.

On the sell side, the largest reduction was Pfizer, an estimated $13.7M trimmed.

  • Iguana Healthcare Management's largest Q2 2015 buy was Amgen: 60,000 shares worth $9.21M.
  • Iguana Healthcare Management added most to Elevance Health in Q2 2015, an estimated $4.79M increase.
  • Iguana Healthcare Management's biggest Q2 2015 reduction was Pfizer, cutting an estimated $13.7M.
  • Iguana Healthcare Management fully exited Allergan plc in Q2 2015, selling an estimated $7.44M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $317M portfolio in Q2 2015.
  • Iguana Healthcare Management opened 36 new positions and closed 29 in Q2 2015.
  • Iguana Healthcare Management's portfolio value rose 33% quarter-over-quarter to $317M.

Based on Iguana Healthcare Management's 13F filing for Q2 2015, filed 14 Aug 2015.